Febbo Phillip G. 4
4 · VERACYTE, INC. · Filed Dec 6, 2024
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Sale
Common Stock
2024-12-04$44.09/sh−3,934$173,447→ 82,414 total
Footnotes (2)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $43.60 to $44.46. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.